Home › Pulmonary Hypertension › Tennessee › Nashville
Pulmonary Hypertension clinical trials in Nashville, TN
4 studies for Pulmonary Hypertension are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
RecruitingPhase 4
- Vanderbilt University & Vanderbilt University Medical Center (VUMC), Nashville
Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension
Recruiting
- Vanderbilt University Medical Center, Nashville
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
RecruitingObservational study
- Vanderbilt University Medical Center, Nashville
Pulmonary Hypertension Association Registry
RecruitingObservational study
- Vanderbilt Children's Hospital, Nashville
- Vanderbilt University Medical Center, Nashville
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Aurora, CO9 studies
- Phoenix, AZ9 studies
- Cincinnati, OH8 studies
- New York City, NY8 studies
- Boston, MA8 studies
- Indianapolis, IN8 studies
- Kansas City, KS8 studies
- Rochester, MN7 studies
- Charleston, SC7 studies
- Salt Lake City, UT7 studies
- Houston, TX7 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.